The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial

Clinical trial NCT02401828 · COMPLETED

Trial details

NCT number: NCT02401828
Sponsor: Erasmus Medical Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Human Immunodeficiency Virus

Start date: 2015-03-01
Primary completion: 2017-06-01
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.